Search results for: Vaccines
Filter search results
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…2014. Accessed February 27, 2024. https://www.ohe.org/news/orphan-drugs-policies-suitable-case-treatment/ Kettler H, Towse A. Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty – OHE. OHE – Leading intellectual…
Insights and Reflections from 2024
8 January 2025, 3:00pm
…Shortages Vaccines Top 10 insights from ISPOR Emerging issues for the year ahead Share this: https://vimeo.com/1032408150 Our panel of OHE experts covered the research trends that had the biggest impact…
New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year
16 December 2024
…key areas of work impacted during a presenteeism day related to error rate and quality (29%), creativity (29%), decision making (27%) and communication (26%). Investments in prevention, including vaccines, hygiene,…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…for the purchase of COVID vaccines. This modelling work with CGD’s Rachel Bonnifield has been adopted and updated by the Alliance for Reducing Microbial Resistance to support EU policy making….
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised….
Policy, Organisation and Incentives in Health Systems
Policy, Organisation and Incentives in Health Systems A key objective for financially constrained health systems, facing a growing and aging population with increasingly complex patients, is to obtain the best…
Measuring Value with Pharmacoeconomics
26 May 2011
…the value of drugs, vaccines and other health technologies. CEA usually is applied within a broader framework of health technology assessment (HTA), whereby the technology is assessed for use and/or…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
…regulatory support for pre-competitive consortia Hybrid Orphan drug legislation Vaccines and drugs to counter chemical, biological, radiological and nuclear (CBRN) threats, including Project BioShield The authors argue that push incentives…
Presentations from ISPOR and HTAi 2018
12 July 2018
…HTA in Incentivising New Drugs and Vaccines to Tackle AMR from Office of Health Economics Optimizing the Use of RWE in HTA: the ICER Membership Summit 2017 from Office…